Methotrexate

NDC 0143-9367 · Hikma Pharmaceuticals USA Inc.

Generic nameMethotrexate

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS

Active ingredient(s)METHOTREXATE

Strength1 g/1

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryANDA

Packages

0143-9367-01 — 1 VIAL in 1 BOX (0143-9367-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

J9260 — Injection, methotrexate sodium, 50 mg Medicare Part B payment limit (ASP + 6%): $2.94

FDA lists these products with the same active ingredient.

0143-9516 — Methotrexate, 0143-9517 — Methotrexate, 0143-9518 — Methotrexate, 0143-9519 — Methotrexate, 0143-9830 — Methotrexate, 0904-7141 — Methotrexate, 16729-277 — Methotrexate, 50268-554 — Methotrexate, 52652-2001 — Methotrexate, 54436-010 — methotrexate, 54436-012 — methotrexate, 54436-015 — methotrexate, 54436-017 — methotrexate, 54436-020 — methotrexate, 54436-022 — methotrexate, 54436-025 — methotrexate, 68382-775 — Methotrexate, 70771-1058 — Methotrexate, 81927-204 — Methotrexate

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.